MedPath

Assesing topical analgesia during painful cures.

Phase 1
Conditions
Evaluate pain reduction during wound cleaning after previous application of topic solution of lidocaine vs. placebo
Therapeutic area: Not possible to specify
Registration Number
EUCTR2017-002352-91-ES
Lead Sponsor
Dra Antònia Dalmau i LLitjós del Servicio de Anestesia, Reanimación y Terapéutica del dolor del HUB -Idibell
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised-recruitment may be ongoing or finished
Sex
All
Target Recruitment
46
Inclusion Criteria

a) signed and dated informed consent before randomization process
b) male or female
c) older or equal to 18 years
d) Patients with painful wound care
e) Wounds or ulcers of any origin (vascular deficit, diabetic, traumatic, postsurgical ...) with skin damaged
f) Women with a negative result on a pregnancy test.
g) Men and women of childbearing potential must agree to use effective contraception throughout treatment
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 46
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 46

Exclusion Criteria

a) history of allergic reaction to local anesthetics of the amide type.
b) Wounds or ulcers of grade I (injury seamless skin)
c) very large wounds (requiring more than 20 ml of solution)
d) periocular Wounds
e) Patients with impaired cardiac conduction atrioventricular block of 2nd or 3rd degree heart block or bifascicular
f) Patients with altered level of consciousness
g) Patients on hemodialysis, peritoneal dialysis or continuous hemofiltration
h) Patients with moderate or severe hepatic impairment
i) Pregnant or breast-feeding.
j) Patients who refuse to participate

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath